ARCHIVES

Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

Center Directors Offer Each Other Advice On how To Prepare for, Handle Reviewers

December 16, 1977

FDA Advisors Okay NCI Toxicology Proposals, Write New Clinical Guidelines, Approve AIN DA

October 19, 1979

Low Percentage Of Trials Published In Medical Journals

October 31, 2008

UPCI To Lead Clinical Trials Of Eli Lilly’s Oncology Agents.

July 6, 2001

Non-Profit Spent $1.3 Million On Consultants.

March 28, 2008

Senate Subcommittee Gives NCI 41.397 Billion for FY ‘87

August 8, 1986